Release of GPI-anchored Membrane Proteins by a Cell-associated GPI-specific Phospholipase D
Overview
Molecular Biology
Authors
Affiliations
Although many glycosylphosphatidylinositol (GPI)-anchored proteins have been observed as soluble forms, the mechanisms by which they are released from the cell surface have not been demonstrated. We show here that a cell-associated GPI-specific phospholipase D (GPI-PLD) releases the GPI-anchored, complement regulatory protein decay-accelerating factor (DAF) from HeLa cells, as well as the basic fibroblast growth factor-binding heparan sulfate proteoglycan from bone marrow stromal cells. DAF found in the HeLa cell culture supernatants contained both [3H]ethanolamine and [3H]inositol, but not [3H]palmitic acid, whereas the soluble heparan sulfate proteoglycan present in bone marrow stromal cell culture supernatants contained [3H]ethanolamine. 125I-labeled GPI-DAF incorporated into the plasma membranes of these two cell types was released in a soluble form lacking the fatty acid GPI-anchor component. GPI-PLD activity was detected in lysates of both HeLa and bone marrow stromal cells. Treatment of HeLa cells with 1,10-phenanthroline, an inhibitor of GPI-PLD, reduced the release of [3H]ethanolamine-DAF by 70%. The hydrolysis of these GPI-anchored molecules is likely to be mediated by an endogenous GPI-PLD because [3H]ethanolamine DAF is constitutively released from HeLa cells maintained in serum-free medium. Furthermore, using PCR, a GPI-PLD mRNA has been identified in cDNA libraries prepared from both cell types. These studies are the first demonstration of the physiologically relevant release of GPI-anchored proteins from cells by a GPI-PLD.
Evaluation of circulating glypican 4 as a novel biomarker in disease - A comprehensive review.
Muendlein A, Leiherer A, Drexel H J Mol Med (Berl). 2025; .
PMID: 39961831 DOI: 10.1007/s00109-025-02520-5.
Sun C, Guo Y, Cong P, Tian Y, Gao X Nutrients. 2023; 15(6).
PMID: 36986087 PMC: 10053018. DOI: 10.3390/nu15061359.
Muller G, Lechner A, Tschop M, Muller T Biomedicines. 2021; 9(3).
PMID: 33802150 PMC: 8000876. DOI: 10.3390/biomedicines9030277.
Horowitz A, Fan X, Bieri G, Smith L, Sanchez-Diaz C, Schroer A Science. 2020; 369(6500):167-173.
PMID: 32646997 PMC: 7879650. DOI: 10.1126/science.aaw2622.
Glypican 3-Targeted Therapy in Hepatocellular Carcinoma.
Nishida T, Kataoka H Cancers (Basel). 2019; 11(9).
PMID: 31510063 PMC: 6770328. DOI: 10.3390/cancers11091339.